Uncategorized
Bimatoprost ocular insert reduces IOP in glaucoma patients over 6 months
NEW ORLEANS — Glaucoma patients implanted with a bimatoprost ocular insert showed a clinically relevant reduction in IOP over 6 months, according to a study presented here. “[In patients with ocular hypertension], we found that lowering IOP by 20% will decrease the relevant risk of developing glaucoma by 60% among the subjects in our study, and if we achieve this sort of efficacy level, we can prevent many patients from diurnal loss and developing vision loss,” John D. Brandt, MD, said at the Ophthalmology Innovation Summit preceding the American Society (Read more...)